NicholasMcAndrewMDMSCE

Breast Cancer

Assistant Professor, Division of Hematology/Oncology, University of California Los Angeles

Dr. McAndrew is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
120 S. Spalding Drive, Suite 401
Beverly Hills, CA 90212
Phone+1 310-205-0771

Fax+1 310-205-0771

Perelman School of Medicine at the University of PennsylvaniaMSCE, Clinical Epidemiology, 2016 - 2018
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2015 - 2018
University of Pennsylvania Health SystemResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012, MD
Villanova UniversityBS, Biology, Manga Cum Laude, 2004 - 2008

PubMed

Surgical outcomes following neoadjuvant chemotherapy with and without immunotherapy in patients with triple-negative breast cancer.
Anouchka Coste Holt, Courtney A Smith, Maurice J Berkowitz, Jennifer L Baker, Nicholas P McAndrew
Discover. Oncology. 2024-09-20
1 citations
Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
Nathan M Kohrman, Jordan R Wlodarczyk, Li Ding, Nicholas P McAndrew, Sandra D Algaze
Diseases of the Colon and Rectum. 2024-07-01
6 citations
Preclinical and clinical activity of DZD1516, a full blood-brain barrier-penetrant, highly selective HER2 inhibitor.
Jian Zhang, Nicholas P McAndrew, Xiaojia Wang, Yiqun Du, Brian DiCarlo
Breast Cancer Research. 2023-07-06

Abstracts/Posters

Neutropenia and response to single agent palbociclib.
Nicholas Patrick McAndrew, Mark Andrew Dickson, Amy Sanders Clark, Andrea Troxel, Christopher Colameco, Maryann Gallagher, Kristi Gramlich, Kelly Zafman, David J. Vaug..., 2018 Annual ASCO Meeting, Chicago, IL, 6/2/2018
Abstract P4-22-14: Single agent palbociclib with or without trastuzumab for the treatment of Rb+ advanced breast cancer
AS Clark, X Wang, A Troxel, J Burrell, M Feldman, P Lal, P Zhang, M Rosen, M Gallagher, J Ndicu, I Nivar, J Matro, SM Domchek, KR Fox, P O'Dwyer and A DeMichele, 2016 San Antonio Breast Cancer Symposium, San Antonio, TX, 12/9/2016
Oncotype DX scores in BRCA1 and BRCA2 associated breast cancer.
Nicholas Patrick McAndrew , Kara Noelle Maxwell , Jill Stopfer , Jacquelyn Powers , Amanda C. Brandt , Jessica M. Long , Katherine L. Nathanson , Susan M. Domchek, 2015 Annual ASCO Meeting, Chicago, IL, 5/30/2015

SABCS: Improved Survival for Advanced Breast Cancer, Using Genomics to Identify Patients with High Risk of Recurrence, How race/ethnicity Influence the Risk of Heart Failure in Early-Stage Breast Cancer and MoreDecember 5th, 2024
Targeted Therapy for Early Breast Cancer and Advances in PSMA PET Scans at ASCOMay 22nd, 2023